Paul Bisaro insider trades: Myriad Genetics (MYGN) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Paul reports to the SEC
and 9 more companies
Open-market buys and sales
42 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 14, 2026 | MYGN | ↑ Buy | 7,500 | $3.69 | $28K | Direct | May 14, 2026 (0d) |
| May 13, 2026 | ZTS | ↑ Buy | 2,000 | $75.88 | $152K | Direct | May 13, 2026 (0d) |
| Mar 14, 2023 | MNK | ↑ Buy | 5,000 | $8.47 | $42K | Direct | Mar 16, 2023 (2d) |
| Aug 16, 2021 | TXMD | ↑ Buy | 50,000 | $0.79 | $40K | Direct | Aug 18, 2021 (2d) |
| Jun 4, 2020 | TXMD | ↑ Buy | 50,000 | $1.14 | $57K | Direct | Jun 8, 2020 (4d) |
| Mar 12, 2019 | AMRX | ↑ Buy | 17,000 | $11.97 | $203K | Direct | Mar 12, 2019 (0d) |
| Mar 2, 2017 | AGN | ↓ Sell | 70,000 | $246.68 | $17.3M | Direct | Mar 6, 2017 (4d) |
| Aug 24, 2015 | AGN | ↑ Buy | 1,000 | $297.42 | $297K | Direct | Aug 24, 2015 (0d) |
| Nov 11, 2013 | ACT | ↓ Sell | 40,921 | $158.73 | $6.5M | Direct | Nov 13, 2013 (2d) |
| Aug 20, 2013 | ACT | ↓ Sell | 50,000 | $135.30 | $6.8M | Direct | Aug 22, 2013 (2d) |
| Oct 22, 2007 | BRL | ↓ Sell | 15,000 | $54.07 | $811K | Direct | Oct 24, 2007 (2d) |
| Oct 19, 2007 | BRL | ↓ Sell | 10,000 | $54.28 | $543K | Direct | Oct 22, 2007 (3d) |
| Oct 18, 2007 | BRL | ↓ Sell | 10,000 | $54.70 | $547K | Direct | Oct 19, 2007 (1d) |
| Oct 17, 2007 | BRL | ↓ Sell | 15,400 | $55.30 | $852K | Direct | Oct 18, 2007 (1d) |
| Oct 11, 2007 | BRL | ↓ Sell | 10,000 | $55.75 | $558K | Direct | Oct 12, 2007 (1d) |
| Oct 10, 2007 | BRL | ↓ Sell | 10,000 | $55.61 | $556K | Direct | Oct 11, 2007 (1d) |
| Oct 9, 2007 | BRL | ↓ Sell | 10,000 | $55.78 | $558K | Direct | Oct 10, 2007 (1d) |
| Oct 5, 2007 | BRL | ↓ Sell | 7,196 | $56.00 | $403K | Direct | Oct 9, 2007 (4d) |
| Oct 2, 2007 | BRL | ↓ Sell | 60,303 | $57.02 | $3.4M | Direct | Oct 3, 2007 (1d) |
| Sep 27, 2007 | BRL | ↓ Sell | 20,000 | $56.08 | $1.1M | Direct | Oct 1, 2007 (4d) |
| Sep 26, 2007 | BRL | ↓ Sell | 25,000 | $55.86 | $1.4M | Direct | Sep 27, 2007 (1d) |
| Sep 24, 2007 | BRL | ↓ Sell | 45,000 | $54.26 | $2.4M | Direct | Sep 25, 2007 (1d) |
| Sep 21, 2007 | BRL | ↓ Sell | 20,000 | $53.56 | $1.1M | Direct | Sep 24, 2007 (3d) |
| Sep 19, 2007 | BRL | ↓ Sell | 10,000 | $53.10 | $531K | Direct | Sep 20, 2007 (1d) |
| Sep 14, 2007 | BRL | ↓ Sell | 5,000 | $51.24 | $256K | Direct | Sep 17, 2007 (3d) |
| Sep 12, 2007 | BRL | ↓ Sell | 5,000 | $52.00 | $260K | Direct | Sep 13, 2007 (1d) |
| Sep 11, 2007 | BRL | ↓ Sell | 5,000 | $52.00 | $260K | Direct | Sep 12, 2007 (1d) |
| Aug 9, 2007 | BRL | ↓ Sell | 37,477 | $55.48 | $2.1M | Direct | Aug 10, 2007 (1d) |
| Jun 18, 2007 | BRL | ↓ Sell | 20,000 | $52.10 | $1.0M | Direct | Jun 20, 2007 (2d) |
| Jun 7, 2007 | BRL | ↓ Sell | 10,000 | $52.29 | $523K | Direct | Jun 8, 2007 (1d) |
| Mar 19, 2007 | BRL | ↓ Sell | 11,850 | $48.27 | $572K | Direct | Mar 20, 2007 (1d) |
| Mar 15, 2007 | BRL | ↓ Sell | 25,700 | $47.52 | $1.2M | Direct | Mar 16, 2007 (1d) |
| Mar 13, 2007 | BRL | ↓ Sell | 20,000 | $47.94 | $959K | Direct | Mar 15, 2007 (2d) |
| Mar 1, 2006 | BRL | ↓ Sell | 15,240 | $66.83 | $1.0M | Direct | Mar 2, 2006 (1d) |
| Feb 1, 2006 | BRL | ↓ Sell | 10,000 | $66.23 | $662K | Direct | Feb 1, 2006 (0d) |
| Jan 3, 2006 | BRL | ↓ Sell | 10,000 | $61.63 | $616K | Direct | Jan 3, 2006 (0d) |
| Nov 1, 2005 | BRL | ↓ Sell | 10,000 | $58.23 | $582K | Direct | Nov 2, 2005 (1d) |
| Oct 3, 2005 | BRL | ↓ Sell | 10,000 | $54.38 | $544K | Direct | Oct 3, 2005 (0d) |
| Sep 1, 2005 | BRL | ↓ Sell | 10,951 | $45.64 | $500K | Direct | Sep 1, 2005 (0d) |
| Aug 1, 2005 | BRL | ↓ Sell | 10,000 | $47.02 | $470K | Direct | Aug 2, 2005 (1d) |
| Jul 1, 2005 | BRL | ↓ Sell | 10,000 | $48.96 | $490K | Direct | Jul 1, 2005 (0d) |
| Jun 15, 2005 | BRL | ↓ Sell | 10,000 | $49.60 | $496K | Direct | Jun 15, 2005 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other MYGN insiders
Open-market trades in the last 12 months
About Paul Bisaro's insider trades
Paul Bisaro is a director at Myriad Genetics (MYGN). Since Jun 15, 2005, Paul has reported 7 open-market purchases worth $819K and 35 sales worth $57.9M on SEC Form 4. In the last 12 months: 2 buys ($179K).
Their filings also include grants and awards (65 filings), option exercises (50 filings), shares withheld for taxes (22 filings), shares returned to the company (8 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MYGN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.